Biotech and pharma react with relief to Makary as FDA commissioner

STAT reporters reached out to key figures in biotech, pharma, and medical gadgets to seek out out what they consider President-elect Trump’s decide of Johns Hopkins pancreatic surgeon Martin “Marty” Makary as commissioner of the Meals and Drug Administration. Makary, like Trump’s supposed Well being and Human Providers choice, Robert F. Kennedy Jr., is a part of the “Make America Wholesome Once more” motion, centered on addressing power illness. He was additionally a critic of some Covid-19 pandemic measure, together with vaccine mandates.

These interviews have been edited and condensed for size and readability. (Some spoke solely on the situation that they not be recognized.)

Jerome Adams, former surgeon normal

“I believe Marty Makary is an affordable decide to guide the FDA, and maybe the least stunning or controversial of all of Trump’s well being picks to this point.”